Citius Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Citius Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q4 2024.
  • Citius Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending December 18, 2024 was 7.73M shares, a 95.1% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 7.73M -151M -95.1% Dec 18, 2024 10-K/A 2025-01-27
Q2 2024 181M +21.9M +13.8% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 181M +21.8M +13.7% May 10, 2024 10-Q 2024-05-14
Q4 2023 159M +12.8M +8.72% Dec 27, 2023 10-K 2023-12-29
Q2 2023 159M +12.7M +8.71% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 159M +12.7M +8.71% May 10, 2023 10-Q 2023-05-12
Q4 2022 146M +182K +0.12% Dec 15, 2022 10-K 2022-12-22
Q2 2022 146M +150K +0.1% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 146M +10.7M +7.87% May 10, 2022 10-Q 2022-05-12
Q4 2021 146M +90.5M +163% Nov 30, 2021 10-K 2021-12-15
Q2 2021 146M +90.5M +163% Aug 10, 2021 10-Q 2021-08-12
Q1 2021 135M +97.3M +255% May 10, 2021 10-Q 2021-05-13
Q4 2020 55.6M +26.6M +92.1% Nov 30, 2020 10-K 2020-12-16
Q2 2020 55.5M +33.4M +151% Aug 10, 2020 10-Q 2020-08-14
Q1 2020 38.1M +16.1M +72.7% May 11, 2020 10-Q 2020-05-14
Q4 2019 28.9M +11.1M +62.5% Dec 9, 2019 10-K 2019-12-16
Q2 2019 22.1M +5.88M +36.3% Aug 7, 2019 10-Q 2019-08-14
Q1 2019 22.1M +11.4M +107% May 8, 2019 10-Q 2019-05-15
Q4 2018 17.8M +9.38M +111% Dec 1, 2018 10-K 2018-12-11
Q2 2018 16.2M +7.95M +96.3% Aug 13, 2018 10-Q 2018-08-14
Q1 2018 10.7M -64.8M -85.9% May 8, 2018 10-Q 2018-05-11
Q4 2017 8.42M -65.7M -88.6% Dec 1, 2017 10-K 2017-12-13
Q2 2017 8.25M -64.8M -88.7% Aug 8, 2017 10-Q 2017-08-14
Q1 2017 75.5M Apr 30, 2017 10-Q 2017-05-15
Q4 2016 74.1M +39.4M +114% Dec 1, 2016 10-K 2016-12-23
Q2 2016 73M +39.3M +116% Aug 10, 2016 10-Q 2016-08-15
Q4 2015 34.7M +4.68M +15.6% Dec 1, 2015 10-K 2015-12-14
Q2 2015 33.8M +15.8M +87.6% Aug 7, 2015 10-Q 2015-08-13
Q1 2015 32.4M +14.4M +80.1% May 8, 2015 10-Q 2015-05-13
Q4 2014 30M +12M +66.8% Dec 19, 2014 10-KT 2014-12-29
Q2 2014 18M Aug 13, 2014 10-Q 2014-08-14
Q1 2014 18M 0 0% May 15, 2014 10-Q 2014-05-15
Q4 2013 18M 0 0% Jan 31, 2014 10-K 2014-02-06
Q3 2013 18M Sep 9, 2013 10-Q 2013-09-18
Q1 2013 18M 0 0% May 1, 2013 10-Q 2013-05-13
Q4 2012 18M 0 0% Jan 4, 2013 10-K 2013-01-15
Q2 2012 18M Jul 31, 2012 10-Q 2012-08-17
Q1 2012 18M Apr 20, 2012 10-Q 2012-05-11
Q4 2011 18M Jan 5, 2012 10-K 2012-01-13
Q3 2011 18M Aug 23, 2011 10-Q 2011-08-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.